未知股票 TBIO 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 177.58万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 4.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 66.4% to $6...
2024-09-27 00:31
Crude Oil Down Over 2%; US Initial Jobless Claims Fall
U.S. stocks traded higher midway through trading, with the Dow Jones index gain...
2024-09-27 00:02
Telesis Bio partners with Danaher company Beckman Coulter
Shares of Telesis Bio (NASDAQ:TBIO) surged ~110% in the premarket on Thursday after the nano-cap life sciences company announced a partnership with Danaher (NYSE:DHR) subsidiary Beckman Coulter Life S...
2024-09-26 20:05
Market-Moving News for September 26th
MU: 17% | Micron shares are trading higher following better-than-expected Q4 financial results. TBIO: 148% | Telesis Bio Partners With Beckman Coulter Life Sciences To Revolutionize DNA And mRNA Synthesis,
2024-09-26 19:59
Telesis Bio Stock Is Soaring Wednesday: What's Going On?
Telesis Bio shares are soaring in extended trading Wednesday after the company announced a partnership to revolutionize DNA and mRNA synthesis.
2024-09-26 04:53
Telesis Bio to delist its securities from Nasdaq
Telesis Bio (NASDAQ:TBIO) said on Tuesday that it has notified Nasdaq of its decision to delist the company’s shares of common stock. Telesis expects that the last trading day of its common stock on t...
2024-09-11 04:45
Telesis Bio Board Shake-Up: New Chair, Committee Restructuring
An announcement from Telesis Bio (TBIO) is now available. Five members of Teles...
2024-08-31 05:57
Telesis Bio (TBIO) Gets a Buy from TD Cowen
In a report released today, Steven Mah from TD Cowen maintained a Buy rating on...
2024-08-08 06:15
Telesis Bio Q2 Adj $(7.62) Misses $(4.03) Estimate, Sales $1.55M Miss $6.50M Estimate
Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(7.62) per share which missed the analyst consensus estimate of $(4.03) by 89.08 percent. This is a 51.19 percent decrease over losses of $(5.04) per share from the
2024-08-08 04:45
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a...
2024-08-08 04:05
